Elafin
| Name | Elafin |
| Category | Disulfide Cyclized Peptides |
| One Letter Code | AQEPVKGPVSTKPGSCPIILIRCAMLNPPNRCLKDTDCPGIKKCCEGSCGMACFVPQ (Disulfide bridge: 16- 45, 23-49, 32- 44, 38- 53) |
| Three Letter Code | {Ala}{Gln}{Glu}{Pro}{Val}{Lys}{Gly}{Pro}{Val}{Ser}{Thr}{Lys}{Pro}{Gly}{Ser}{Cys}{Pro}{Ile}{Ile}{Leu}{Ile}{Arg}{Cys}{Ala}{Met}{Leu}{Asn}{Pro}{Pro}{Asn}{Arg}{Cys}{Leu}{Lys}{Asp}{Thr}{Asp}{Cys}{Pro}{Gly}{Ile}{Lys}{Lys}{Cys}{Cys}{Glu}{Gly}{Ser}{Cys}{Gly}{Met}{Ala}{Cys}{Phe}{Val}{Pro}{Gln} (Disulfide bridge: 16-45, 23-49, 32-44, 38-53) (Disulfide bridge: 16- 45, 23-49, 32- 44, 38- 53) |
| Molecular Weight | 5999.300 |
| Application |
| King, Anne E., et al. "Elafin in human endometrium: an antiprotease and antimicrobial molecule expressed during menstruation." The Journal of Clinical Endocrinology & Metabolism 88.9 (2003): 4426-4431. |
| Wiedow, Oliver, Jens Lüdemann, and Bert Utecht. "Elafin is a potent inhibitor of proteinase 3." Biochemical and biophysical research communications 174.1 (1991): 6-10. |
| Tremblay, Guy M., et al. "Elafin/elastase-specific inhibitor in bronchoalveolar lavage of normal subjects and farmer's lung." American journal of respiratory and critical care medicine 154.4 (1996): 1092-1098. |
| Simpson, A. John, et al. "Adenoviral augmentation of elafin protects the lung against acute injury mediated by activated neutrophils and bacterial infection." The Journal of Immunology 167.3 (2001): 1778-1786. |